Avalyn Pharma

AVLN

26.6005.44% ( -1.530 )

Trading: Oct 5, 12:16:29 (EDT)

Forecast & Rating5 analysts currently cover Avalyn Pharma, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $61.80, about 132.3% upside from the current price of $26.60. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most professionals who study Avalyn Pharma closely still see room for the stock to rise. Data as of Oct 4, 2026; for reference only and not investment advice.

Oct 2, 2026

Price forecast

$61.80132.33%

Forecast & RatingStrong buy

5analysts

Forecast dateOct 5, 2026

Forecast met0.0%

Stock price$26.60

Avg. target$61.8

High target$80

Low target$52

Strong buy

Buy

Hold

Sell

Strong sell

Source: S&P Global

This information is for reference only and is not investment advice.